Your browser doesn't support javascript.
loading
Effect of local steroids on urethral strictures: A systematic review and meta-analysis.
Soliman, Christopher; Pan, Henry Y C; Mulholland, Clancy J; Furrer, Marc A; Agarwal, Dinesh K; Lawrentschuk, Nathan; Sathianathen, Niranjan J.
Afiliação
  • Soliman C; Department of Urology, The Royal Melbourne Hospital, Parkville, VIC, Australia. chrissol1312@gmail.com.
  • Pan HYC; Department of Urology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Mulholland CJ; Department of Urology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Furrer MA; Department of Urology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Agarwal DK; Department of Urology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Lawrentschuk N; Department of Urology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Sathianathen NJ; Department of Urology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
Investig Clin Urol ; 63(3): 273-284, 2022 05.
Article em En | MEDLINE | ID: mdl-35534216
PURPOSE: Urethral stricture disease is common and has high associated morbidity and impact on quality-of-life. This systematic review and meta-analysis aims to summarise current evidence on the efficacy of local urethral steroids post-direct vision internal urethrotomy (DVIU) for the treatment of urethral strictures in males. MATERIALS AND METHODS: A comprehensive search was performed using reputable databases and registries, up to 22 February 2022. Only randomised control trials in which participants were randomised to DVIU plus local urethral steroids versus DVIU only were included. Statistical analyses were performed using a random-effects model. Quality of evidence was rated according to the GRADE approach. RESULTS: The search identified seven studies in which 365 participants were randomised to DVIU plus local urethral steroids versus DVIU only. The application of local steroids appeared to reduce recurrence rates (risk ratio, 0.67; 95% confidence interval [CI], 0.49-0.90) and time-to-recurrence (hazard ratio, 0.58; 95% CI, 0.39-0.85). Qmax also improved following steroid application (mean difference, 0.82; 95% CI, -1.02-2.66); however, this was not statistically significant. No heterogeneity was identified between included studies for all outcomes. The certainty of evidence was downgraded due to study limitations with a small sample size and unclear risk-of-bias related to insufficient trial information. CONCLUSIONS: Compared to DVIU alone, adjuvant steroids applied to the urethra may reduce risk of recurrence and time-to-recurrence. These findings were statistically significant and likely also clinically significant given low associated costs and risk. However, more robust randomised trials are necessary to enhance the validity of these outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estreitamento Uretral Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estreitamento Uretral Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article